Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 416 | 68,566 | 354 | 348 | 695 |
| Cost of Goods | N/A | N/A | 354 | 348 | 695 |
| Gross Profit | 416 | N/A | N/A | N/A | 0 |
| Operating Expenses | 3,083 | 20,124 | 14,873 | 15,205 | 18,570 |
| Operating Income | -2,667 | 48,442 | -14,519 | -14,857 | -17,875 |
| Interest Expense | 50 | 0 | 0 | 0 | 0 |
| Other Income | 407 | 11 | -112 | -16 | 0 |
| Pre-tax Income | -2,310 | 48,453 | -14,631 | -14,873 | -17,875 |
| Net Income Continuous | -2,310 | 48,453 | -14,631 | -14,873 | -17,875 |
| Net Income Discontinuous | -1,293 | 29,249 | -14,334 | 127,154 | -31,146 |
| Net Income | $-3,603 | $77,702 | $-28,965 | $112,281 | $-49,021 |
| EPS Basic Total Ops | -0.37 | 8.41 | -3.13 | 12.83 | -5.70 |
| EPS Basic Continuous Ops | -0.24 | 5.48 | -1.58 | -1.70 | -2.08 |
| EPS Basic Discontinuous Ops | -0.13 | 2.93 | -1.55 | 14.53 | -3.62 |
| EPS Diluted Total Ops | -0.37 | 7.96 | -3.13 | 12.83 | -5.70 |
| EPS Diluted Continuous Ops | -0.24 | 5.47 | -1.58 | -1.70 | -2.08 |
| EPS Diluted Discontinuous Ops | -0.13 | 2.48 | -1.55 | 14.53 | -3.62 |
| EBITDA(a) | $-2,640 | $48,751 | $-14,246 | $-14,575 | $-17,546 |